Regulation (EC) No 999/2001 of the European Parliament and of the CouncilDangos y teitl llawn

[F1 3. Points values and point targets U.K.

Surveillance samples must meet the point targets set out in Table 2, on the basis of ‘ point values ’ fixed in Table 1. All clinical suspects shall be investigated, regardless of the number of points accumulated. A country shall sample at least three out of the four sub-populations. The total points for samples collected shall be accumulated over a period of a maximum of seven consecutive years to achieve the target number of points. The total points accumulation shall be periodically compared to the target number of points for a country or region.

Table 1

Surveillance point values for samples collected from animals in the given sub-population and age category

a Bovine animals over 36 months of age at routine slaughter.
b Bovine animals over 30 months of age which are found dead or killed on farm, during transport or at an abattoir (fallen stock).
c Bovine animals over 30 months of age that are non-ambulatory, recumbent, unable to rise or to walk without assistance; bovine animals over 30 months of age sent for emergency slaughter or with abnormal observations at ante-mortem inspection (casualty or emergency slaughter).
d Bovine animals over 30 months of age displaying behavioural or clinical signs consistent with BSE (clinical suspects).
Surveillance sub-population
Routine slaughter a	Fallen stock b	Casualty slaughter c	Clinical suspect d
Age ≥ 1 year and < 2 years
0,01	0,2	0,4	N/A
Age ≥ 2 years and < 4 years (young adult)
0,1	0,2	0,4	260
Age ≥ 4 years and < 7 years (middle adult)
0,2	0,9	1,6	750
Age ≥ 7 years and < 9 years (older adult)
0,1	0,4	0,7	220
Age ≥ 9 years (aged)
0,0	0,1	0,2	45

[F2 Table 2

Points targets for different adult bovine animals population sizes in a country or region

Points targets for country or region
Adult bovine animals population size (24 months and older)	Type A surveillance	Type B surveillance
> 1 000 000	300 000	150 000
900 001 - 1 000 000	214 600	107 300
800 001 - 900 000	190 700	95 350
700 001 - 800 000	166 900	83 450
600 001 - 700 000	143 000	71 500
500 001 - 600 000	119 200	59 600
400 001 - 500 000	95 400	47 700
300 001 - 400 000	71 500	35 750
200 001 - 300 000	47 700	23 850
100 001 - 200 000	22 100	11 500
90 001 - 100 000	19 900	9 950
80 001 - 90 000	17 700	8 850
70 001 - 80 000	15 500	7 750
60 001 - 70 000	13 000	6 650
50 001 - 60 000	11 000	5 500
40 001 - 50 000	8 800	4 400
30 001 - 40 000	6 600	3 300
20 001 - 30 000	4 400	2 200
10 001 - 20 000	2 100	1 050
9 001 - 10 000	1 900	950
8 001 - 9 000	1 600	800
7 001 - 8 000	1 400	700
6 001 - 7 000	1 200	600
5 001 - 6 000	1 000	500
4 001 - 5 000	800	400
3 001 - 4 000	600	300
2 001 - 3 000	400	200
1 001 - 2 000	200	100] ]

Textual Amendments

F2 Substituted by Commission Regulation (EU) No 1148/2014 of 28 October 2014 amending Annexes II, VII, VIII, IX and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).

Textual Amendments

F1 Substituted by Commission Regulation (EC) No 722/2007 of 25 June 2007 amending Annexes II, V, VI, VIII, IX and XI to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).